National Bank of Canada’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$222 Hold
127
﹤0.01% 2790
2025
Q4
$297 Buy
127
+45
+55% +$123 ﹤0.01% 2724
2025
Q3
$251 Sell
82
-60,842
-100% -$174K ﹤0.01% 2732
2025
Q2
$170K Buy
60,924
+60,524
+15,131% +$199K ﹤0.01% 1650
2025
Q1
$1.43K Buy
400
+376
+1,567% +$1.51K ﹤0.01% 2540
2024
Q4
$76 Hold
24
﹤0.01% 2813
2024
Q3
$68 Sell
24
-1
-4% -$2 ﹤0.01% 2583
2024
Q2
$30 Hold
25
﹤0.01% 2663
2024
Q1
$20 Hold
25
﹤0.01% 2696
2023
Q4
$24 Hold
25
﹤0.01% 2683
2023
Q3
$26 Hold
25
﹤0.01% 2742
2023
Q2
$22 Hold
25
﹤0.01% 2699
2023
Q1
$21 Hold
25
﹤0.01% 2671
2022
Q4
$23 Hold
25
﹤0.01% 2737
2022
Q3
$0 Hold
25
﹤0.01% 2717
2022
Q2
$0 Hold
25
﹤0.01% 2807
2022
Q1
$0 Sell
25
-37,100
-100% -$108K ﹤0.01% 2868
2021
Q4
$137K Buy
+37,125
New +$228K ﹤0.01% 1554

Other funds holding CLOV

National Bank of Canada's CLOV Position: Q1 2026 in Review

National Bank of Canada held its Clover Health Investments (CLOV) position steady in Q1 2026 at 127 shares worth $222. The position accounts for ﹤0.01% of the portfolio, ranked #2790.

National Bank of Canada first reported a position in CLOV in Q4 2021 and has held it in 18 quarters since. The position peaked at $170K in Q2 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • National Bank of Canada held 127 shares of Clover Health Investments worth $222 as of Q1 2026.
  • National Bank of Canada left its Clover Health Investments share count unchanged in Q1 2026.
  • Clover Health Investments made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2790 holding.
  • National Bank of Canada first reported a position in Clover Health Investments in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Clover Health Investments position peaked at $170K in Q2 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.